SMOORE International Reports 2022 Financial Performance

Mar.21.2023
SMOORE International Reports 2022 Financial Performance
Smoore International's 2022 performance report indicates an 11.7% decline in revenue and a 52.7% decrease in net profit.

On March 20th, Semiconductor Manufacturing International Corporation (SMIC) released its 2022 financial performance report. The report revealed that SMIC had a revenue of 12.145 billion yuan in 2022, a decrease of 11.7% from the previous year. After adjustments, their net profit for the year was 2.575 billion yuan, a decrease of 52.7% from the previous year.


Summary of SMIC's Financial Report | Source: SMIC Financial Report


More than 80% of overseas revenue: Decline in the US, Rise in Europe. According to the financial report, Smore's total revenue for 2022 was CNY 12.145 billion, with an export income of CNY 9.898 billion accounting for 81.5% of the total revenue, an increase of 15.5% compared to last year. Domestic sales revenue was CNY 2.246 billion, accounting for 18.5% of the total revenue, a decrease of 15.5% compared to last year.


Market Revenue in Simoer | Source: Simoer Financial Report


In 2022, Smoore's sales revenue for enterprise customers in the United States decreased by 22.7% due to increased competition from non-compliant electronic cigarette products and price adjustments for certain products to support some clients in gaining market share. This decline was analyzed by region.


In the financial report, Somor expressed confidence in the future competitiveness of its products and long-term growth in the US market, as the FDA continues to strengthen its enforcement efforts.


In Europe and other markets, Smoore's sales revenue in 2022 increased by 53.4% compared to the previous year. Smoore stated in their financial report that they have assisted major clients in becoming the top electronic cigarette brand in several European countries.


In China, Synergy, a company that specializes in providing marketing solutions, saw a 51.9% year-on-year decrease in sales revenue specifically to enterprise customers. This has had a significant negative impact on Synergy's overall revenue.


Business Type Revenue for SMIC | Source: SMIC Financial Report


The revenue of the company's disposable electronic cigarette products was 1.9 billion yuan, over 19 times higher than the previous year.


According to the financial report, Smoore recently launched a new line of disposable e-cigarettes in the European market, leading to a rapid increase in sales. In 2022, the revenue from disposable products amounted to 1.93 billion yuan, representing a growth of 1919% compared to the 0.95 billion yuan in 2021. Notably, the revenue from the second half of the year reached 1.61 billion yuan, reflecting a year-over-year increase of 1761%.


In addition, in the second half of 2022, Simoer upgraded their open system product LUXE X, further increasing their market share.


According to the financial report, in 2022, Simoer's revenue from sales of products to retail customers was 1.465 billion yuan, a year-on-year increase of 26.2%.


Research and development investment doubled, enhancing the competitiveness of core brands.


According to the financial report, in 2022, Smoore invested 1.372 billion yuan in research and development, an increase of 104% compared to the previous year. Of this, 74% was spent on electronic nicotine delivery systems (including electronic vaporization and non-combustible heating products), 13.9% on specialty vaporization products, and 12.1% on vaporization medical and beauty products.


Silmor R&D expenses | Source: Silmor financial report


According to financial reports, in 2022, Smor added 2,254 patents, including 1,125 invention patents.


In terms of brand building, SMOORE has announced that it will continue to focus on its manufacturing brand "SMOORE" and create three distinct technology brands: FEELM representing closed-system vaping products, METEX representing non-combustible heating products, and VAPORESSO representing open-system vaping products.


According to SiMoEr, in the future, they plan to launch new products with differentiation in the fields of electronic cigarette devices, specialized nebulization products, and nebulized medicine, expanding the scope of nebulization technology applications.


Reference:


As of December 31st, 2022, the annual performance report for Sumo International Holdings Limited has been announced.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | PMI Japan Launches SENTIA Passion Fruit Capsule, Expanding the IQOS ILUMA Flavor Portfolio
Product | PMI Japan Launches SENTIA Passion Fruit Capsule, Expanding the IQOS ILUMA Flavor Portfolio
Philip Morris Japan (PM Japan) has introduced SENTIA Passion Fruit Capsule, a new tobacco stick designed for the IQOS ILUMA heated tobacco platform. Featuring a crush-activated capsule, the product combines menthol with passion fruit flavor to provide an additional flavor experience. The product launched in Japan from August 3, 2026, through IQOS official channels, convenience stores and tobacco retailers.
Aug.04
FDA Proposes Foreign Tobacco Factory Registration Rule to Tighten Import Oversight
FDA Proposes Foreign Tobacco Factory Registration Rule to Tighten Import Oversight
The FDA has proposed a rule requiring foreign tobacco manufacturers to register facilities and list products before exporting to the U.S. If finalized, the rule could affect overseas OEM/ODM factories, contract manufacturers, specification developers, bulk product makers, and repackaging or relabeling firms. FDA says the proposal would help identify unauthorized imported tobacco products, including e-cigarettes.
Special Report
Jun.26
BAT Regional Director Fred Monteiro Supports Spain’s Nicotine Rules but Opposes 0.99mg Nicotine Pouch Limit
BAT Regional Director Fred Monteiro Supports Spain’s Nicotine Rules but Opposes 0.99mg Nicotine Pouch Limit
Spanish newspaper El Confidencial interviewed Fred Monteiro, Regional Director for Americas and Europe at British American Tobacco (BAT). Monteiro said BAT supports setting regulatory limits for nicotine products but opposes Spain’s proposed 0.99mg nicotine-per-pouch limit, arguing that such a restriction could affect adult smokers’ transition to alternatives. He said nicotine regulation should be based on scientific evidence and harm reduction principles. Monteiro also said smoke-free products now account for around 25% of BAT’s Americas and Europe business and nearly 30% of its Europe business
BAT
Jul.30
PMI to Launch IQOS in Argentina by End-2026 After Regulatory Shift, Targeting About 7 Million Smokers
PMI to Launch IQOS in Argentina by End-2026 After Regulatory Shift, Targeting About 7 Million Smokers
Philip Morris International (PMI) has confirmed plans to bring its IQOS heated tobacco device to Argentina by the end of 2026, after the Argentine government lifted long-standing restrictions and created a regulatory framework for heated tobacco, e-cigarettes and nicotine pouches.
News
Jun.26 by 2Firsts Perspectives
Imperial Brands Plans Thousands of Job Cuts Across U.S. and Europe in Cost Restructuring
Imperial Brands Plans Thousands of Job Cuts Across U.S. and Europe in Cost Restructuring
According to Reuters, citing Bloomberg News, British tobacco company Imperial Brands PLC plans to cut thousands of jobs across the United States and Europe as part of a cost reduction and organizational restructuring effort. The announcement drew market attention to the company’s shares. The move comes as global tobacco companies continue adjusting their operations amid slower cigarette market growth, changing consumer preferences and the transition toward next-generation nicotine products.
Aug.11
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
As e-cigarettes, heated tobacco products and nicotine pouches expand across global markets, a central question is gaining urgency: can tobacco control rely on a universal policy model? In an interview with 2Firsts, Asian public health and addiction medicine specialist Dr. Rashidi Mohamed bin Pakri Mohamed says Western experience remains relevant, but policies must be adapted to local culture, healthcare systems, enforcement capacity, illicit markets and clinical evidence.
Jul.08